3-acetyl-7-[6-[3-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]propylamino]-6-oxohexoxy]-N-[2-fluoro-5-(hydroxymethyl)-3-(1-methylpyrazol-4-yl)phenyl]indolizine-1-carboxamide

InChIKey	`VVOJECSTVKGBLZ-UHFFFAOYSA-N`
Compound Name	3-acetyl-7-[6-[3-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]propylamino]-6-oxohexoxy]-N-[2-fluoro-5-(hydroxymethyl)-3-(1-methylpyrazol-4-yl)phenyl]indolizine-1-carboxamide
Canonical SMILES	`CC(=O)c1cc(C(=O)Nc2cc(CO)cc(-c3cnn(C)c3)c2F)c2cc(OCCCCCC(=O)NCCCc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)ccn12`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	6.87
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q09472	EP300	Homo sapiens	Human	PF00439 PF09030 PF08214 PF02172 PF23570 PF06001 PF02135 PF00569	7.3	IC50	ChEMBL
Q92793	CREBBP	Homo sapiens	Human	PF00439 PF09030 PF08214 PF02172 PF23570 PF06001 PF02135 PF00569	7.2	IC50	ChEMBL
Q96SW2	CRBN	Homo sapiens	Human	PF02190 PF03226	6.1	IC50	ChEMBL